JoVE Logo
Faculty Resource Center

Sign In

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells

DOI :

10.3791/52446-v

11:37 min

February 18th, 2015

February 18th, 2015

13,414 Views

1Women's Malignancies Branch, National Cancer Institute

Tumor-initiating cells (TICs) may represent a viable therapeutic target for the treatment of ovarian cancer, a highly recurrent and fatal disease. We present a protocol for culture conditions that enrich for this highly tumorigenic population of cells.

Tags

In Vitro Enrichment

-- Views

Related Videos

article

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth

article

In vitro Mesothelial Clearance Assay that Models the Early Steps of Ovarian Cancer Metastasis

article

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

article

Label-free Isolation and Enrichment of Cells Through Contactless Dielectrophoresis

article

Method for Obtaining Primary Ovarian Cancer Cells From Solid Specimens

article

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time

article

Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines

article

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

article

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

article

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved